MX9305445A - Tabletas farmaceuticas de liberacion programada. - Google Patents
Tabletas farmaceuticas de liberacion programada.Info
- Publication number
- MX9305445A MX9305445A MX9305445A MX9305445A MX9305445A MX 9305445 A MX9305445 A MX 9305445A MX 9305445 A MX9305445 A MX 9305445A MX 9305445 A MX9305445 A MX 9305445A MX 9305445 A MX9305445 A MX 9305445A
- Authority
- MX
- Mexico
- Prior art keywords
- naproxen
- release
- released
- dry
- tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Se proporcionan tabletas de liberación programada que van a administrarse por vía oral, que contienen 500 a 1,200 mg de naproxen, fabricadas por mezclas de granulado compacto, seco de liberación inmediata que contienen de 5 a 28 de naproxen, de un granulado compacto seco, de liberación controlada, que contiene de 72 a 92 de naproxen y de un agente de desintegración. Una porción del naproxen es liberada en un tiempo corto, de tal manera que la droga se desarrolla rápidamente su acción terapéutica alcanzando los niveles hemáticos necesarios, mientras que la porción restante es liberada en un intervalo de tiempo prolongado mientras que aún permite cubrir el efecto terapéutico efectivo durante un periodo de 24 horas; de esta forma, las tabletas objeto de la presente invención son adecuadas para la administración una vez al día.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITBO920315A IT1258143B (it) | 1992-09-11 | 1992-09-11 | Compresse a cessione programmata contenenti naproxen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9305445A true MX9305445A (es) | 1994-05-31 |
Family
ID=11338458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9305445A MX9305445A (es) | 1992-09-11 | 1993-09-06 | Tabletas farmaceuticas de liberacion programada. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5480650A (es) |
| EP (1) | EP0587065B1 (es) |
| KR (1) | KR970008157B1 (es) |
| CN (1) | CN1088091A (es) |
| AT (1) | ATE148340T1 (es) |
| AU (1) | AU669552B2 (es) |
| CA (1) | CA2105541C (es) |
| CZ (1) | CZ279853B6 (es) |
| DE (1) | DE69307807T2 (es) |
| DK (1) | DK0587065T3 (es) |
| ES (1) | ES2097952T3 (es) |
| FI (1) | FI933975L (es) |
| GR (1) | GR3022434T3 (es) |
| IL (1) | IL106943A (es) |
| IS (1) | IS1624B (es) |
| IT (1) | IT1258143B (es) |
| MX (1) | MX9305445A (es) |
| NO (1) | NO304260B1 (es) |
| NZ (1) | NZ248574A (es) |
| ZA (1) | ZA936445B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5609884A (en) * | 1992-08-31 | 1997-03-11 | G. D. Searle & Co. | Controlled release naproxen sodium plus naproxen combination tablet |
| US8022095B2 (en) * | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US6153225A (en) * | 1998-08-13 | 2000-11-28 | Elan Pharma International Limited | Injectable formulations of nanoparticulate naproxen |
| US6165506A (en) * | 1998-09-04 | 2000-12-26 | Elan Pharma International Ltd. | Solid dose form of nanoparticulate naproxen |
| CN1434704A (zh) * | 1999-12-16 | 2003-08-06 | 三叉技术有限责任公司 | 延长其受体负荷剂量的治疗剂释放的系统和方法 |
| WO2004060355A1 (en) * | 2002-12-26 | 2004-07-22 | Pozen Inc. | Multilayer Dosage Forms Containing NSAIDs and Triptans |
| CA2592605C (en) | 2004-12-27 | 2010-12-07 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| AU2009220779A1 (en) * | 2008-03-05 | 2009-09-11 | Panacea Biotec Limited | Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
| US20090252791A1 (en) * | 2008-04-02 | 2009-10-08 | Venkata Nookaraju Sreedharala | Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug |
| US20090311335A1 (en) * | 2008-06-12 | 2009-12-17 | Scott Jenkins | Combination of a triptan and an nsaid |
| US8618157B2 (en) * | 2008-06-20 | 2013-12-31 | Alphapharm Pty. Ltd. | Pharmaceutical formulation |
| PL2919903T3 (pl) | 2012-11-14 | 2020-12-14 | W.R. Grace & Co. - Conn. | Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1200178B (it) * | 1986-07-23 | 1989-01-05 | Alfa Farmaceutici Spa | Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica |
| IT1215726B (it) * | 1988-01-18 | 1990-02-22 | Alfa Wassermann Spa | Formulazioni galeniche a cessione programmata. |
| US5232705A (en) * | 1990-08-31 | 1993-08-03 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
| US5204116A (en) * | 1991-05-01 | 1993-04-20 | Alza Corporation | Dosage form providing immediate therapy followed by prolonged therapy |
-
1992
- 1992-09-11 IT ITBO920315A patent/IT1258143B/it active IP Right Grant
-
1993
- 1993-09-01 IS IS4069A patent/IS1624B/is unknown
- 1993-09-01 CZ CZ931806A patent/CZ279853B6/cs not_active IP Right Cessation
- 1993-09-01 US US08/115,897 patent/US5480650A/en not_active Expired - Fee Related
- 1993-09-01 ZA ZA936445A patent/ZA936445B/xx unknown
- 1993-09-02 NZ NZ248574A patent/NZ248574A/en unknown
- 1993-09-03 AT AT93114151T patent/ATE148340T1/de not_active IP Right Cessation
- 1993-09-03 ES ES93114151T patent/ES2097952T3/es not_active Expired - Lifetime
- 1993-09-03 EP EP93114151A patent/EP0587065B1/en not_active Expired - Lifetime
- 1993-09-03 DK DK93114151.9T patent/DK0587065T3/da active
- 1993-09-03 CA CA002105541A patent/CA2105541C/en not_active Expired - Fee Related
- 1993-09-03 DE DE69307807T patent/DE69307807T2/de not_active Expired - Fee Related
- 1993-09-06 MX MX9305445A patent/MX9305445A/es not_active IP Right Cessation
- 1993-09-07 IL IL10694393A patent/IL106943A/en not_active IP Right Cessation
- 1993-09-07 NO NO933177A patent/NO304260B1/no not_active IP Right Cessation
- 1993-09-08 CN CN93116664A patent/CN1088091A/zh active Pending
- 1993-09-08 AU AU46202/93A patent/AU669552B2/en not_active Ceased
- 1993-09-10 FI FI933975A patent/FI933975L/fi not_active Application Discontinuation
- 1993-09-10 KR KR1019930018163A patent/KR970008157B1/ko not_active Expired - Fee Related
-
1997
- 1997-01-30 GR GR970400110T patent/GR3022434T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1088091A (zh) | 1994-06-22 |
| NO933177L (no) | 1994-03-14 |
| NZ248574A (en) | 1995-04-27 |
| FI933975A7 (fi) | 1994-03-12 |
| IT1258143B (it) | 1996-02-20 |
| IL106943A (en) | 1998-09-24 |
| US5480650A (en) | 1996-01-02 |
| AU669552B2 (en) | 1996-06-13 |
| CZ279853B6 (cs) | 1995-07-12 |
| IS1624B (is) | 1996-10-18 |
| GR3022434T3 (en) | 1997-04-30 |
| DE69307807T2 (de) | 1997-05-15 |
| NO933177D0 (no) | 1993-09-07 |
| ZA936445B (en) | 1995-01-31 |
| KR970008157B1 (ko) | 1997-05-21 |
| ES2097952T3 (es) | 1997-04-16 |
| KR940006577A (ko) | 1994-04-25 |
| CA2105541C (en) | 1999-01-05 |
| EP0587065A1 (en) | 1994-03-16 |
| DK0587065T3 (da) | 1997-06-09 |
| ITBO920315A0 (it) | 1992-09-11 |
| DE69307807D1 (de) | 1997-03-13 |
| CA2105541A1 (en) | 1994-03-12 |
| AU4620293A (en) | 1994-03-17 |
| ATE148340T1 (de) | 1997-02-15 |
| CZ180693A3 (en) | 1994-03-16 |
| ITBO920315A1 (it) | 1994-03-11 |
| NO304260B1 (no) | 1998-11-23 |
| EP0587065B1 (en) | 1997-01-29 |
| FI933975A0 (fi) | 1993-09-10 |
| IS4069A (is) | 1994-03-12 |
| FI933975L (fi) | 1994-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9305445A (es) | Tabletas farmaceuticas de liberacion programada. | |
| ES2152966T3 (es) | Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion. | |
| DK0577504T3 (da) | Niacin-holdige sustained release-tabletter og -kits | |
| ES2161882T3 (es) | Forma de dosificacion oral de metoprolol, de una vez al dia. | |
| ES2099977T3 (es) | Composiciones de liberacion prolongada para tratar enfermedades periodontales. | |
| ES2090368T3 (es) | Composiciones farmaceuticas que contienen glucosaminoglicanos absorbibles por via oral. | |
| ES2045153T3 (es) | Metodo para la preparacion de formas de dosificacion de farmacos con liberacion sostenida que contienen hidroxi-propil-metilcelulosa y carboxilatos de metales alcalinos. | |
| DE69627817D1 (de) | Pharmazeutische zubereitung, die fenofibrat und polyglykolisierte glyceride enthält | |
| ES2176436T3 (es) | Nueva forma de dosificacion farmaceutica oral. | |
| ES2174073T3 (es) | Forma farmaceutica solida para uso oral. | |
| AR002754A1 (es) | Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento | |
| CA2029046A1 (en) | Sustained release compositions for treating periodontal disease | |
| FI940787A7 (fi) | Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa | |
| ES2057124T3 (es) | Producto terapeutico para el tratamiento de estados peri- o post-menopausicos. | |
| DE69326539D1 (de) | Zytotoxische arzneimittel therapie | |
| ES2185816T3 (es) | Formas de dosificacion farmaceutica para la via oral, que comprenden un agente inhibidor de la bomba de protones y un agente procinetico. | |
| ZA924482B (en) | Matrix tablet permitting the sustained release of indapamide after oral administration | |
| ES2161809T3 (es) | Uso de factor proliferativo osteoblastico. | |
| AR002968A1 (es) | Uso de hirudina y acido acetilsalicilico para la preparacion de un medicamento para tratar un infarto de miocardio agudo en pacientes nosometidos a tratamiento trombolitico y una composicion farmaceutica. | |
| ATE250414T1 (de) | Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure | |
| ES2107400T1 (es) | Nueva utilizacion terapeutica de superoxidos dismutasas. | |
| ATE257377T1 (de) | Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform | |
| UY30293A1 (es) | Formulaciones de dosificacion oral de polipeptidos resistentes a proteasas y usos de los mismos para tratamiento | |
| CO5360642A1 (es) | Composicion de liberacion dual de un inhibidor de ciclooxigenasa-2 | |
| DK86093D0 (da) | Praeparat til medikamentel behandling for tandlaegebrug mod lidelserne tandkoedsbetaendelse og tandnervebetaendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |